We propose to renew the NCI Cancer Epidemiology Training Program. We propose to continue to support 12 trainees per year, but have adjusted the proportions to meet NCI recommendations, and propose three pre-doctoral students and nine postdoctoral fellows. We leverage the enormously rich academic environment of the Harvard T.H. Chan School of Public Health, together with the Dana- Farber/Harvard Cancer Center, Channing Division of Network Medicine and a multitude of affiliated institutions. These resources include the Harvard cohorts (Nurses? Health Studies I,II, and III, Health Professionals Follow-up Study, Physicians? Health Study, Women?s Health Study, the VITAL trial,and others). These cohorts have millions of person-years of repeated follow-up for all cancer sites, as well as blood and tissue samples from over 100,000 individuals. The opportunities for cancer research within this environment are virtually limitless. We have brought together outstanding faculty mentors to provide integrated interdisciplinary experiences and collaborative interactions, a specialized curriculum with core and elective coursework, nondidactic practical career training, individual candidate training plans, and ongoing Program evaluation. Cutting-edge didactic training and mentoring will create a new generation of highly skilled and enthusiastic investigators to study factors that influence cancer incidence and survival. A major focus is to take advantage of the multitude of modern ?omics methods, such as genomics, metabolomics, together with the array of biologic samples, including blood, oral swabs and stool for microbiome, and tumor tissue. The multidisciplinary training will include applying modern epidemiologic and biostatistical methods to analyze such data, and develop novel approaches for cancer research. This training program is currently in year 42; we have constantly updated the program, taking advantage of approaches that work well, initiating new aspects, and taking advantage of new opportunities, and revise our mentor group accordingly. One constant feature is that we have never had a shortage of outstanding candidates for the program. With continued support, we believe this training program will continue to have a major impact to further the mission of NCI to reduce the burden of cancer through prevention and improved survival.

Public Health Relevance

This program aims to train a new generation of investigators to understand how behavioral and environmental factors affect risk of cancer incidence and survival, and to integrate the wealth of new methods in molecular biology (such as genomics and metabolomics), epidemiology, and biostatistics in this effort. Through multidisciplinary training, and leveraging the enormous resources that are available to our students and post- doctoral fellows, we believe that great strides can be made to reduce the burden of cancer in the US and around the world.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA009001-45
Application #
9928360
Study Section
Subcommittee I - Transistion to Independence (NCI)
Program Officer
Schmidt, Michael K
Project Start
1978-07-01
Project End
2024-06-30
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
45
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Harvard University
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02115
Seyerle, A A; Sitlani, C M; Noordam, R et al. (2018) Pharmacogenomics study of thiazide diuretics and QT interval in multi-ethnic populations: the cohorts for heart and aging research in genomic epidemiology. Pharmacogenomics J 18:215-226
Busch, Evan L; Don, Prabhani Kuruppumullage; Chu, Haitao et al. (2018) Diagnostic accuracy and prediction increment of markers of epithelial-mesenchymal transition to assess cancer cell detachment from primary tumors. BMC Cancer 18:82
Alotaibi, Nawaf M; Noormohamed, Nadia; Cote, David J et al. (2018) Physiologic Growth Hormone-Replacement Therapy and Craniopharyngioma Recurrence in Pediatric Patients: A Meta-Analysis. World Neurosurg 109:487-496.e1
Kamran, Sophia C; Seisen, Thomas; Markt, Sarah C et al. (2018) Contemporary Treatment Patterns and Outcomes for Clinical Stage IS Testicular Cancer. Eur Urol 73:262-270
Busch, Evan L; Whitsel, Eric A; Kroenke, Candyce H et al. (2018) Social relationships, inflammation markers, and breast cancer incidence in the Women's Health Initiative. Breast 39:63-69
Taber, Jennifer M; Dickerman, Barbra A; Okhovat, Jean-Phillip et al. (2018) Skin cancer interventions across the cancer control continuum: Review of technology, environment, and theory. Prev Med 111:451-458
Geller, Alan C; Dickerman, Barbra A; Taber, Jennifer M et al. (2018) Skin cancer interventions across the cancer control continuum: A review of experimental evidence (1/1/2000-6/30/2015) and future research directions. Prev Med 111:442-450
Hirko, Kelly A; Chai, Boyang; Spiegelman, Donna et al. (2018) Erythrocyte membrane fatty acids and breast cancer risk: a prospective analysis in the nurses' health study II. Int J Cancer 142:1116-1129
Simon, Tracey G; King, Lindsay Y; Chong, Dawn Q et al. (2018) Diabetes, metabolic comorbidities, and risk of hepatocellular carcinoma: Results from two prospective cohort studies. Hepatology 67:1797-1806
Graff, Rebecca E; Ahearn, Thomas U; Pettersson, Andreas et al. (2018) Height, Obesity, and the Risk of TMPRSS2:ERG-Defined Prostate Cancer. Cancer Epidemiol Biomarkers Prev 27:193-200

Showing the most recent 10 out of 472 publications